Poor survival of ABG I hip prosthesis in younger patients

Area of Science:

• Orthopedic Surgery
• Biomaterials Science
• Medical Device Engineering

Background:

• Hydroxyapatite coated (HAC) hip implants have a long clinical history.
• Existing studies often lack long-term outcome data, limiting predictions of implant longevity.
• This study focuses on the long-term performance of HAC total hip arthroplasty in a younger patient demographic.

Purpose of the Study:

• To evaluate the 10-year performance and survival rate of hydroxyapatite coated (HAC) total hip arthroplasty in younger patients.
• To identify the primary reasons for implant failure and revision in this cohort.
• To assess the impact of specific factors, such as cup size, on implant survival.

Main Methods:

• An observational retrospective study design was employed.
• 137 consecutive cases using the ABG I prosthesis were analyzed, with 128 hips available for final assessment.
• Kaplan-Meier survival analysis was used to estimate implant survival probability over 12 years.

Main Results:

• The overall 12-year cumulative survival rate for the implants was 0.55.
• Periprosthetic osteolysis (57%) and aseptic loosening (28%) were the most common reasons for failure.
• Smaller acetabular component size was identified as a significant risk factor for revision due to wear-related complications (OR=4.3).

Conclusions:

• The study indicates suboptimal 12-year survivorship for cementless acetabular components, particularly in younger patients.
• High rates of osteolysis, linked to polyethylene wear, were the primary drivers of premature implant failure.
• These findings highlight potential concerns regarding the long-term durability of certain HAC hip implant designs.